285 results on '"Dunbar, Richard"'
Search Results
52. Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to Niacin
53. Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled Trial.
54. Oral Apolipoprotein A‐I Mimetic D‐4F Lowers HDL‐Inflammatory Index in High‐Risk Patients: A First‐in‐Human Multiple‐Dose, Randomized Controlled Trial
55. Genetic coding variants in the niacin receptor, hydroxyl–carboxylic acid receptor 2, and response to niacin therapy
56. Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E
57. Familial Chylomicron Syndrome: Importance of Discerning the Rare Among the Common
58. Retrospective Review of the Effect of Alirocumab on Apheresis
59. Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimetics
60. A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans
61. A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis
62. Familial Chylomicronemia Syndrome: Distinguishing the Rare Among the Common in Adults for Appropriate Management†
63. Misery loves companies
64. Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
65. Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein
66. Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects
67. Familial Chylomicronemia Syndrome With a Novel Homozygous LPL Mutation Identified in Three Siblings in Their 50s.
68. Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial
69. Phase 1 Single and Multiple Ascending Dose Study of CAT-2003, a Novel Activator of Lipoprotein Lipase, Decreases Postprandial Triglycerides†
70. Systemic Eicosanoid and Cytokine Response to Niacin: Implications in HPS2-THRIVE Trial and Beyond†∗
71. PHASE 1 SINGLE AND MULTIPLE ASCENDING DOSE STUDY OF CAT-2003, A NOVEL ACTIVATOR OF LIPOPROTEIN LIPASE, DEMONSTRATES REDUCTIONS IN POSTPRANDIAL TRIGLYCERIDES
72. Abstract 18721: Diacylglycerol Kinase ? (DGKB) Genotype Predicts Response to Niacin Induced Flushing and Changes in Insulin in the Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes (AIM-HIGH) Trial
73. Combined forced and free turbulent convection in a vertical tube with volume heat sources and constant wall heat addition
74. Antisense Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
75. Pharmacokinetic Interactions of the Microsomal Triglyceride Transfer Protein Inhibitor, Lomitapide, with Drugs Commonly Used in the Management of Hypercholesterolemia
76. Discordance between non-HDL-cholesterol and LDL-particle measurements: Results from the Multi-Ethnic Study of Atherosclerosis
77. Abstract 390: Perilipin 1 (plin1) Genotype and Not Gpr109a Associated with Free Fatty Acid Rebound Following Niacin Administration
78. Epanova Lowers Apolipoprotein C-III and Increases LDL-Particle Size in Statin-Treated Patients With Mild Hypertriglyceridemia
79. Abstract 439: Niacin Does Not Accelerate Reverse Cholesterol Transport in Man
80. Differences in absolute risk of cardiovascular events using risk-refinement tests: A systematic analysis of four cardiovascular risk equations
81. A HIGHLY BIOAVAILABLE OMEGA-3 FREE-FATTY ACID REDUCES NON-HIGH DENSITY LIPOPROTEIN CHOLESTEROL IN HIGH-RISK PATIENTS TREATED WITH A STATIN AND RESIDUAL HYPERTRIGLYCERIDEMIA (ESPRIT TRIAL)
82. Abstract 19030: Apolipoprotein C-III is Significantly Reduced by Prescription Omega-3 Free Fatty Acids (Epanova) in Patients with Severe Hypertriglyceridemia and Changes Correlate with Increases in LDL-C: A Sub-analysis of the EVOLVE trial
83. Intraindividual variability of C-reactive protein: The Multi-Ethnic Study of Atherosclerosis
84. Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression
85. Abstract 19: Single-Dose Extended-Release Niacin Acutely Attenuates HDL Reduction in the Setting of Experimental Oral Fat Challenge: A Possible Role of ANGPTL-3 and CETP Modulation
86. Could Exercise Metabolomics Pave the Way for Gymnomimetics?
87. TRIPLE THERAPY WITH STATIN, FIBRATE (TRILIPIX) AND NIACIN RAISES HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WITHOUT CHANGING APOLIPOPROTEIN A-I LEVELS
88. FENOFIBRIC AND NICOTINIC ACID PROGRESSIVELY SUPPRESS POSTPRANDIAL TRIGLYCERIDEMIA IN STATIN-TREATED PATIENTS WITH LOW HIGH-DENSITY LIPOPROTEIN CHOLESTEROL
89. A Single Dose of Extended-Release Niacin Suppresses Postprandial Triglyceridemia in Healthy Volunteers
90. Potent and Selective PPAR-α Agonist LY518674 Upregulates Both ApoA-I Production and Catabolism in Human Subjects With the Metabolic Syndrome
91. Abstract 3705: Pioglitazone Augments Niacin-Induced Increases in Adiponectin in Non-Diabetics with Metabolic Syndrome and Low HDL
92. 103: Changes in Core Temperature Are Related to Free Fatty Acid Rebound from Niacin
93. Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients
94. Constrictive pericarditis
95. Swip's Dunbar: Markets must prepare for elevated food prices
96. The Unsung Perils of Peripheral Arterial Disease: A Malady in Search of a Patient
97. CHAPTER 43: HYPERTENSION, LIPOPROTEIN ABNORMALITIES, AND THE METABOLIC SYNDROME.
98. The children here
99. Production, Characterization, and Utilization of Aerosol-Deposited Sol−Gel-Derived Films
100. On the Local Environment Surrounding Pyrene in Near- and Supercritical Water
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.